Overview

A Phase III Study of Comparing Paclitaxel Plus 5-Fluorouracil Versus Cisplatin Plus 5-Fluorouracil in Chemoradiotherapy for Locally Advanced Esophageal Carcinoma

Status:
Completed

Trial end date:
2018-08-01

Target enrollment:

Participant gender:

Summary

The primary objective of this trial is to study whether paclitaxel plus 5-fluorouracil has better overall survival than cisplatin plus 5-fluorouracil in chemoradiotherapy for patients with locally advanced esophageal squamous cell carcinoma. 436 patients will be recruited into this study.

Phase:

Phase 3

Details

Lead Sponsor:

Fudan University

Collaborators:

Affiliated Hospital of Jiangnan University
First Affiliated Hospital of Zhejiang University
Fujian Cancer Hospital
Jiangsu Cancer Institute & Hospital
The First Affiliated Hospital of Xiamen University

Treatments:

Albumin-Bound Paclitaxel
Cisplatin
Fluorouracil
Paclitaxel